Levoxyl Market

Levoxyl is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland.
Levoxyl Market contains market size and forecasts of Levoxyl in global, including the following market information:
Global Levoxyl Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Levoxyl Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Levoxyl companies in 2021 (%)
The global Levoxyl market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Levoxyl include Abbvie, Mylan, Merck, King Pharmaceuticals (Pfizer), Lannett Company, Novartis, Fresenius Kabi, IBSA and Piramal Critical Care, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Levoxyl manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Levoxyl Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levoxyl Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Levoxyl Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levoxyl Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pharmacy
Others
Global Levoxyl Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levoxyl Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Levoxyl revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Levoxyl revenues share in global market, 2021 (%)
Key companies Levoxyl sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Levoxyl sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Mylan
Merck
King Pharmaceuticals (Pfizer)
Lannett Company
Novartis
Fresenius Kabi
IBSA
Piramal Critical Care
Abbott
Jerome Stevens